June 1, 2016 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/ researchfunding/newsletter/ 2016/Pages/0601.aspx
Feature Articles
Apply Early to Guard Against Electronic Submission Errors
To successfully submit an electronic grant application, you need to pass two automated systems validations: Grants.gov and eRA Commons.
Opportunities and Resources
New Opportunities to Better Understand Lyme Disease and Tickborne Co-Infections
NIAID invites applications to support research that increases understanding of Lyme disease and co-infections transmitted by Ixodes ticks.
Investigate Immune Mechanisms to Advance New Tuberculosis Vaccines
NIAID seeks grant applications that propose innovative research into innate or adaptive immune responses induced by mycobacterial infections, Bacillus Calmette-Guérin vaccine, or candidate Mycobacterium tuberculosis vaccines in HIV-positive or uninfected people.
The "ImmPort" of a New Funding Opportunity
You may have used or read about NIAID's Immunology Database and Analysis Portal (ImmPort). If so, you may be interested in a recent funding opportunity announcement focused on informatics methodology and secondary analyses for immunology data in ImmPort.
In The News
NIAID Reissues Investigator-Initiated Clinical Trial FOAs
If you’ve previously applied for investigator-initiated clinical trial (IICT) funding and plan to apply again, be aware of several points of emphasis in the set of IICT funding opportunity announcements we reissued in May.
News Briefs
- Respond to Office of AIDS Research RFI on FY 2018 Plan
- Zika Research Included in the Immunity in Neonates and Infants FOA
- New and Improved NIAID Website Coming in September
Advice Corner
Remember to Get Prior Approval for Some Post-Award Actions
Once you receive a grant award, keep in mind that you'll have to get NIAID's permission before making some changes to your funded project.
Reader Questions
- What will take place during the June 6, 2016 Council meeting?
- Where can I find scientific review group rosters?
New Funding Opportunities
- PAR-16-297, Native American Research Centers for Health (NARCH)
- PA-16-107, Modeling of Infectious Disease Agent Study Research Projects
- PA-16-289, Research Supplements to Promote Reentry into Biomedical and Behavioral Research Careers (Admin Supp)
- PA-16-288, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
- PA-16-287, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
- PA-16-286, Successor-in-
Interest (Type 6 Parent) - PA-16-285, Change of Grantee Organization (Type 7 Parent)
- RFA-AI-16-038, Silencing of HIV-1 Proviruses
- PA-16-294, NIH Support for Conferences and Scientific Meetings (Parent R13)
- RFA-AI-16-050, Systems Approach to Immunity and Inflammation
- RFA-AI-16-031, Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention
- PAR-16-275, Serious Adverse Drug Reaction Research (R01)
- PAR-16-274, Serious Adverse Drug Reaction Research (R21)
- RFP-NIAID-DMID-NIHAI2016061, S
tructural Genomics Centers for Infectious Diseases - RFA-HG-16-016, BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science
- RFA-AI-16-047, Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development
- PAR-16-272, NIAID Clinical Trial Planning Grant
- PAR-16-271, NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement
- PAR-16-270, NIAID Clinical Trial Implementation Cooperative Agreement
- PAR-16-269, NIAID Clinical Trial Implementation Grant
See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario